Condensed Consolidated Statements Of Comprehensive Income/(Loss) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Revenue:
Total revenues	$ 0	$ 0	$ 0	$ 0
Operating expenses
Research and development	443,380	355,300	1,495,201	713,585
General and administrative	489,545	121,053	1,357,044	627,605
Total operating expenses	932,925	476,353	2,852,245	1,341,190
Loss from operations	(932,925)	(476,353)	(2,852,245)	(1,341,190)
Interest income	7,036	9,988	23,927	74,006
Net loss	(925,889)	(466,365)	(2,828,318)	(1,267,184)
Other comprehensive income (loss):
Foreign currency translation adjustment	(38,626)	36,641	(311,718)	398,705
Comprehensive loss	$ (964,515)	$ (429,724)	$ (3,140,036)	$ (868,479)
Loss per share
Basic and diluted			$ (0.02)
Weighted Average Number of Shares Outstanding	205,407,088	121,411,478	172,179,520	177,035,840